elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33811677-31173182-9E66-4220-8833-9106CE15A3F0
Q33811677-31173182-9E66-4220-8833-9106CE15A3F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33811677-31173182-9E66-4220-8833-9106CE15A3F0
Are we taking full advantage of the growing number of pharmacological treatment options for osteoporosis?
P2860
Q33811677-31173182-9E66-4220-8833-9106CE15A3F0
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33811677-31173182-9E66-4220-8833-9106CE15A3F0
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7e753aa9d3834f5abdc6eaf2c59221bd2a16a16
P2860
Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties